June 30, 2008 USA
Diamyd Phase III trial - Update
Diamyd has received the first US institutional ethic's committee approval, for the type 1
diabetes Phase III trial. Several more are under review and can expected shortly.
Everything remains on track and continues as planned.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.